Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Acadia Pharmaceuticals
Company

Acadia Pharmaceuticals

Tracked across 1 events · 10 articles · First seen Feb 02, 2026 · Last active Mar 02, 2026

Sentiment
-50
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 -50
Regulatory
Acadia Pharmaceuticals' Trofinetide Rejected by EU Regulator
Acadia Pharmaceuticals Inc. received a negative opinion from the European Union===European Medicines Agency's Committee for Medicinal Products for Human Use regarding the marketing authorization for trofinetide. This decision impacts Acadia Pharmaceuticals Inc.'s ability to commercialize trofinetide in the European Union, potentially limiting its market reach and revenue from this drug.
Feb 02, 2026 · 10 articles
Relationships (1)
Catherine Owen Adams CEO of ↔ Acadia Pharmaceuticals Catherine Owen Adams is the Chief Executive Officer of Acadia Pharmaceuticals In
NEWSDESK
Track Acadia Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.